Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
Crossref DOI link: https://doi.org/10.1007/s00259-014-2822-7
Published Online: 2014-06-06
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sasanelli, Myriam
Meignan, Michel
Haioun, Corinne
Berriolo-Riedinger, Alina
Casasnovas, René-Olivier
Biggi, Alberto
Gallamini, Andrea
Siegel, Barry A.
Cashen, Amanda F.
Véra, Pierre
Tilly, Hervé
Versari, Annibale
Itti, Emmanuel
Text and Data Mining valid from 2014-06-06